Boston Scientific(BSX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BSX Boston Scientific

Market Closed 12-12 16:00:00 EST

92.58

+0.83

+0.90%

盘后92.25

-0.33-0.36%

19:56 EST

High93.38	Low91.53	Vol7.78M
Open92.21	D1 Closing91.75	Amplitude2.01%
Mkt Cap137.24B	Tradable Cap136.78B	Total Shares1.48B
T/O717.84M	T/O Rate0.53%	Tradable Shares1.48B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BSX","market":"US","secType":"STK","nameCN":"Boston Scientific","latestPrice":92.58,"timestamp":1765573200000,"preClose":91.75,"halted":0,"volume":7775383,"hourTrading":{"tag":"盘后","latestPrice":92.25,"preClose":92.58,"latestTime":"19:56 EST","volume":588350,"amount":54469334.8417,"timestamp":1765587401236},"delay":0,"floatShares":1477475891,"shares":1482442039,"eps":1.869975,"marketStatus":"Market Closed","change":0.83,"latestTime":"12-12 16:00:00 EST","open":92.21,"high":93.375,"low":91.53,"amount":717842252.74069,"amplitude":0.020109,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.869975,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":91.75,"preHourTrading":{"tag":"盘前","latestPrice":92.34,"preClose":91.75,"latestTime":"09:29 EST","volume":7603,"amount":699694.160482,"timestamp":1765549799076},"postHourTrading":{"tag":"盘后","latestPrice":92.25,"preClose":92.58,"latestTime":"19:56 EST","volume":588350,"amount":54469334.8417,"timestamp":1765587401236},"volumeRatio":0.6602282771076262,"optionData":{"bulkOrders":[{"symbol":"BSX","call":true,"expireDate":1768539600000,"strike":"95.0","timestamp":1765552872112,"price":2,"volume":2000,"amount":400000,"type":"+"}]},"impliedVol":0.2296,"impliedVolPercentile":0.18},"requestUrl":"/m/hq/s/BSX/wiki","defaultTab":"wiki","newsList":[{"id":"2591365854","title":"Is Boston Scientific’s Valuation Still Justified After Recent Acquisition Driven Growth?","url":"https://stock-news.laohu8.com/highlight/detail?id=2591365854","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591365854?lang=en_us&edition=fundamental","pubTime":"2025-12-13 23:34","pubTimestamp":1765640078,"startTime":"0","endTime":"0","summary":"If you are wondering whether Boston Scientific at around $92 a share is still a smart buy or if the big gains are already behind it, this breakdown is for you.\nThe stock has slipped about 5.1% over the last week and 11.1% over the past month, but it is still up 3.6% year to date and 102.1% over three years and 161.2% over five years, which highlights its longer term momentum.\nRecent headlines have focused on Boston Scientific's continued expansion in minimally invasive cardiovascular and...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/317627-main-header/1756255518234","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/317627-main-header/1756255518234"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bsx/boston-scientific/news/is-boston-scientifics-valuation-still-justified-after-recent","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bsx/boston-scientific/news/is-boston-scientifics-valuation-still-justified-after-recent","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1989772840.SGD","IE00BJT1NW94.SGD","IE0002141913.USD","LU2362541513.USD","LU1718418525.SGD","DCF","LU2242649171.HKD","LU1023059063.AUD","LU0225283273.USD","LU0353189680.USD","LU1057294990.SGD","SG9999001176.USD","BK4082","LU2491050154.USD","LU1989771016.USD","SG9999013999.USD","LU0950375773.USD","LU1989764664.SGD","LU2324357040.USD","BK4581","BK4588","LU0823416689.USD","LU1291159041.SGD","LU1366192091.USD","LU1720051108.HKD","LU2244417387.USD","LU0122379950.USD","LU1791710582.SGD","IE00BJJMRZ35.SGD","LU0251132253.USD","LU0823417737.USD","LU0048584097.USD","LU1989772923.USD","LU0238689110.USD","LU2362540622.SGD","BK4585","LU1061106388.HKD","LU0114720955.EUR","LU2112291526.USD","LU0187121727.USD","LU2506952170.USD","SGXZ57979304.SGD","LU1153585028.USD","LU0011850046.USD","LU1804176565.USD","LU2362541273.HKD","LU0077335932.USD","LU0353189763.USD","LU0823417653.USD","BSX"],"gpt_icon":0},{"id":"2590324433","title":"Boston Scientific Corp. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2590324433","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590324433?lang=en_us&edition=fundamental","pubTime":"2025-12-10 05:36","pubTimestamp":1765316160,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Boston Scientific Corp.  shed 1.40% to $92.53 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.09% to 6,840.51 and Dow Jones Industrial Average  falling 0.38% to 47,560.29.This was the stock's seventh consecutive day of losses.Boston Scientific Corp. closed 15.50% below its 52-week high of $109.50, which the company reached on September 9th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Abbott Laboratories  fell 0.69% to $121.25, Medtronic PLC  fell 1.62% to $99.62, and Stryker Corp.  fell 1.24% to $349.23.Trading volume  eclipsed its 50-day average volume of 9.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled December 9, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Do","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX"],"gpt_icon":0},{"id":"2590366201","title":"Boston Scientific Files Initial Beneficial Ownership Statement for EVP, Global Operations Padraig Andrew O'Connor","url":"https://stock-news.laohu8.com/highlight/detail?id=2590366201","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590366201?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:50","pubTimestamp":1765230611,"startTime":"0","endTime":"0","summary":"Boston Scientific Corporation has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing lists Padraig Andrew O'Connor, who serves as Executive Vice President, Global Operations, as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Boston Scientific Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 08, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDLbR0DFY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0353189680.USD","LU1366192091.USD","LU1989772923.USD","LU2357305700.SGD","LU0251132253.USD","IE0002141913.USD","LU0011850046.USD","IE00BFTCPJ56.SGD","LU1983299246.USD","LU1989772840.SGD","LU2491050071.SGD","BK4581","LU2506952170.USD","LU2242649171.HKD","LU1057294990.SGD","LU1548497426.USD","LU1291159041.SGD","LU1153585028.USD","SG9999001176.SGD","IE0009355771.USD","BK4082","LU0048584097.USD","LU1720051017.SGD","LU0353189763.USD","LU0187121727.USD","LU2265009873.SGD","IE00BJJMRZ35.SGD","LU2506952097.USD","LU2362541273.HKD","BK4585","LU0950375773.USD","LU2324357040.USD","LU2491049909.HKD","LU0122379950.USD","LU0267386448.USD","LU0823416689.USD","LU1804176565.USD","LU1023059063.AUD","LU0345769631.USD","LU1718418525.SGD","LU1720051108.HKD","LU1791710400.SGD","LU1989764664.SGD","LU0432979614.USD","LU2491050154.USD","BSX","LU2087625088.SGD","IE00B2B36J28.USD","LU0266013472.USD","LU1989764748.USD"],"gpt_icon":0},{"id":"2590436669","title":"Boston Scientific Corp. Stock Slips 3.8%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2590436669","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590436669?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:34","pubTimestamp":1765229640,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Boston Scientific Corp. slid 3.8% to $93.84 on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.3% to 6,846.51 and Dow Jones Industrial Average falling 0.4% to 47,739.32.This was the stock's sixth consecutive day of losses.Boston Scientific Corp. closed 14.3% below its 52-week high of $109.50, which the company achieved on September 9th.The stock underperformed when compared to some of its peers, as Abbott Laboratories fell 2.4% to $122.09, Medtronic PLC fell 0.1% to $101.26, and Stryker Corp. fell 2.86% to $353.60.Trading volume totaled 14.7 million, compared to the 50-day average of 9.0 million.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX"],"gpt_icon":0},{"id":"2590357525","title":"BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EST","url":"https://stock-news.laohu8.com/highlight/detail?id=2590357525","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590357525?lang=en_us&edition=fundamental","pubTime":"2025-12-09 01:00","pubTimestamp":1765213207,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. ESTS&P 500 .SPXTop PerformersPercent ChangeParamount Skydance Corp PSKY.OQ+6.7%Weyerhaeuser Co WY.N+4.2%Warner Bros Discovery Inc WBD.OQ+3.9%Arista Networks Inc ANET.N+3.4%Wynn Resorts Ltd WYNN.OQ+3.2%Bottom PerformersPercent ChangeAir Products and Chemicals Inc APD.N-7.7%Dollar General Corp DG.N-5.4%Lululemon Athletica Inc LULU.OQ-4.2%Boston Scientific Corp BSX.N-4.2%Netflix Inc NFLX.OQ-4.2%As of 12:00 p.m., the S&P 500 .SPX lost 24.98 points, or 0.36%, to 6,845.42 and had posted 20 new 52-week highs and 8 new lows.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nL8N3XE1NN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1201861249.SGD","LU1989771016.USD","BK4108","IE00BKVL7J92.USD","LU0203201768.USD","LU1894683264.USD","LU2896262040.SGD","LU2023250504.SGD","LU2361044865.SGD","LU2458330169.SGD","SGXZ99366536.SGD","LU0203202063.USD","BK4503","LU2361045086.USD","BSX","IE00BN0W2W23.USD","LU1023059063.AUD","LU1670627923.USD","SGXZ23171101.USD","SG9999001176.USD","LU0823416689.USD","LU0210536198.USD","LU1430594728.SGD","LU0353189680.USD","LU0417517546.SGD","LU0127658192.USD","LU2491050071.SGD","SGXZ51526630.SGD","LU1674673691.USD","LU2242649171.HKD","LU1093756325.SGD","IE0009355771.USD","LU2506952170.USD","SG9999001424.SGD","WY","LU1674673428.USD","LU1232071149.USD","LU1127390331.HKD","BK4084","LU0114720955.EUR","LU0882574055.USD","LU2264538146.SGD","SG9999001176.SGD","APD","LU0823417653.USD","LU0889565833.HKD","LU0648001328.SGD","LU1974910355.USD","LU1989772923.USD","LU0082616367.USD","IE00B19Z8X17.USD","BK4532","WBD","IE00BQXX3C00.GBP","IE00BZ1G4Q59.USD","LU1791710400.SGD","LU1585245621.USD","LU0256863902.USD","LU1720051017.SGD","LU0942090050.USD","BK4114","LU2286300806.USD","LU0154236417.USD","LU0868494617.USD","LU1366192091.USD","LU1917777945.USD","LU2237957902.USD","LU2362541513.USD","LU0238689110.USD","LU0266013472.USD","LU2361044949.HKD","IE00B2B36J28.USD","BK4221","LU2357305700.SGD","IE00B4R5TH58.HKD","LU0109392836.USD","LU0234572021.USD","LU0006306889.USD","LU0557290698.USD","ANET","LU2458330243.SGD","IE00BQXX3D17.EUR","LU1894683348.USD","LU1791710582.SGD","LU0187121727.USD","IE00BMPRXQ63.HKD","BK4155","BK4550","BK4598","IE00B19Z8W00.USD","BK4524","BK4543","LU2324357040.USD","LU0300736492.USD","LU1803068979.SGD","BK4082","IE00BKPKM429.USD","SG9999004303.SGD","SGXZ57979304.SGD","BK4507","LU0528227936.USD","LU0048584097.USD","LU2491050154.USD","LULU","LU2506951875.HKD","LU1035775433.USD","LU1989763427.SGD","IE00BJJMRZ35.SGD","IE00B19Z9505.USD","BK4548","LU1823568750.SGD","BK4585","LU0106261372.USD","SG9999013999.USD","LU0823411888.USD","LU1435385759.SGD","LU1670628061.USD","IE00BJT1NW94.SGD","LU1804176565.USD","LU0215105999.USD","LU0345769128.USD","LU2461242641.AUD","DG","IE00BN0W2V16.EUR","LU2265009873.SGD","LU2108987350.USD","LU2326559502.SGD","LU0267386448.USD","WYNN","IE0002141913.USD","LU0077335932.USD","PSKY","LU2211815571.USD","LU0079474960.USD","LU0642271901.SGD","LU0256863811.USD","LU0251132253.USD","LU2362541273.HKD","LU0109391861.USD","LU0432979614.USD","LU1061106388.HKD","LU1988902786.USD","IE00BN0W2T93.GBP","LU2237957811.SGD","LU0786609619.USD","IE0008368304.USD","LU2355687059.USD","LU2506952097.USD","LU1153585028.USD","LU1814569148.SGD","LU1291159041.SGD","LU1074936037.SGD","BK4527","LU1989763690.USD","LU0130102774.USD","LU1069344957.HKD","LU2491049909.HKD","LU0980610538.SGD","BK4587","LU1064131342.USD","IE00BMPRXR70.SGD","LU0882574139.USD","IE00BFTCPJ56.SGD","LU0130517989.USD","LU0348723411.USD","LU0122379950.USD","LU1989764664.SGD","BK4150","LU2506951958.HKD","LU0149725797.USD","LU0300736062.USD","LU2552382132.HKD","LU0353189763.USD","LU0950375773.USD","BK4202","LU0097036916.USD","LU2087625088.SGD","LU2112291526.USD","LU2543165471.USD","LU0011850046.USD","LU2362540622.SGD","BK4020","BK4534","BK4588","IE00BQXX3F31.USD","LU0868494708.USD","LU1093756168.USD","LU1429558221.USD","BK4504","BK4554","LU0719512351.SGD","SGXZ81514606.USD","LU1983299246.USD","LU2106854487.HKD","LU2244417387.USD","LU1496350502.SGD","BK4101","LU1316542783.SGD","LU2054465674.USD","NFLX","LU0823417737.USD","LU1267930730.SGD","LU0708995401.HKD","LU1989772840.SGD","LU1720051108.HKD","BK4566","LU0210533765.USD","LU0225283273.USD","LU2860962120.EUR","BK4551","LU0477156953.USD","BK4125","LU1989764748.USD","LU0345769631.USD","LU0234570918.USD","LU2552382058.USD","LU1548497426.USD","BK4581","IE00BMPRXN33.USD","LU2552382215.SGD","LU1046421795.USD","LU0320765059.SGD","LU1718418525.SGD","LU0672654240.SGD","LU1778281490.HKD","LU1057294990.SGD"],"gpt_icon":0},{"id":"2588019988","title":"Acotec Scientific Gains PRC Approval for Microcatheter V-Otter","url":"https://stock-news.laohu8.com/highlight/detail?id=2588019988","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588019988?lang=en_us&edition=fundamental","pubTime":"2025-12-03 16:42","pubTimestamp":1764751368,"startTime":"0","endTime":"0","summary":"Acotec Scientific Holdings Ltd. has announced that it received registration approval from the PRC National Medical Products Administration for its Microcatheter V-otter. The V-otter microcatheter is designed for Transarterial Chemoembolization  procedures and features a large-lumen design to prevent intraoperative catheter occlusion, as well as three different tip configurations to accommodate various clinical needs. The company plans to initiate marketing activities for the product in the PRC market when appropriate.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acotec Scientific Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDL4q8TJV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX","LU1366192091.USD","LU1023059063.AUD","LU1791710400.SGD","LU1791710582.SGD","LU1804176565.USD","LU1057294990.SGD","LU2491050154.USD","BK1100","LU2087625088.SGD","LU1989772840.SGD","LU0225283273.USD","LU2506951958.HKD","LU0823416689.USD","LU2491049909.HKD","LU2362541513.USD","LU1153585028.USD","LU1720051108.HKD","LU2362540622.SGD","LU2244417387.USD","BK1587","LU1989772923.USD","LU2242649171.HKD","06669","IE00BFTCPJ56.SGD","LU0251132253.USD","LU0187121727.USD","LU0950375773.USD","LU0345769128.USD","LU2265009873.SGD","SG9999013999.USD","LU2357305700.SGD","BK4581","LU1061106388.HKD","LU0048584097.USD","LU0882574055.USD","SGXZ57979304.SGD","LU0353189763.USD","LU1989764748.USD","LU0432979614.USD","LU1718418525.SGD","IE0009355771.USD","LU2324357040.USD","IE00B4R5TH58.HKD","BK4588","LU0823417653.USD","IE00BJT1NW94.SGD","LU2491050071.SGD","SG9999001176.SGD","LU1983299246.USD"],"gpt_icon":0},{"id":"2588069619","title":"Boston Scientific Corp. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2588069619","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588069619?lang=en_us&edition=fundamental","pubTime":"2025-12-03 05:37","pubTimestamp":1764711420,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Boston Scientific Corp.  shed 1.97% to $99.02 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.25% to 6,829.37 and the Dow Jones Industrial Average  rising 0.39% to 47,474.46.This was the stock's second consecutive day of losses.Boston Scientific Corp. closed 9.57% short of its 52-week high of $109.50, which the company reached on September 9th.The stock underperformed when compared to some of its competitors Tuesday, as Abbott Laboratories  fell 1.32% to $126.32, Medtronic PLC  fell 1.27% to $102.03, and Stryker Corp.  fell 1.51% to $366.68.Trading volume  remained 1.3 million below its 50-day average volume of 9.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled December 2, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independentl","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX"],"gpt_icon":0},{"id":"2586440441","title":"Press Release: Miami International Holdings Announces Sale of MIAXdx to Robinhood Markets in Partnership with Susquehanna International Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2586440441","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586440441?lang=en_us&edition=fundamental","pubTime":"2025-11-26 06:20","pubTimestamp":1764109200,"startTime":"0","endTime":"0","summary":"Miami International Holdings to Retain 10% Stake in the Exchange and Clearinghouse. PRINCETON, N.J. and MIAMI, Nov. 25, 2025 /PRNewswire/ -- Miami International Holdings, Inc.  , a technology-driven leader in building and operating regulated financial markets across multiple asset classes, today announced it has entered into an agreement to sell 90% of the issued and outstanding equity in MIAX Derivatives Exchange , a wholly owned subsidiary of MIAX, to Robinhood Markets, Inc.   in partnership with Susquehanna International Group. MIAX will retain the remaining 10% of the issued and outstanding equity of MIAXdx.MIAXdx is a Designated Contract Market  and Derivatives Clearing Organization  with regulatory approval from the Commodity Futures Trading Commission  to list and clear fully collateralized futures, options on futures and swaps.Miami International Holdings, Inc.  is a technology-driven leader in building and operating regulated financial markets across multiple asset classes and","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","DCO","LU1061106388.HKD","BK4585","LU1791710582.SGD","LU0114720955.EUR","LU2491049909.HKD","R","LU2491050154.USD","LU2357305700.SGD","BK4504","LU1720051108.HKD","LU2506952097.USD","LU2087625088.SGD","SG9999013999.USD","LU0048584097.USD","LU1366192091.USD","LU0823417653.USD","SG9999001176.USD","BK4112","TM","IE00B7SZL793.SGD","BK4187","LU0238689110.USD","BSX","HOOD","IE00BJT1NW94.SGD","03160","LU1989764748.USD","LU1989764664.SGD","IE00B19Z4B17.USD","IE0002141913.USD","LU1548497426.USD","LU2506952170.USD","LU1791710400.SGD","LU2362541513.USD","LU0528227936.USD","LU1989772923.USD","IE00B4R5TH58.HKD","LU1057294990.SGD","LU2244417387.USD","LU0011850046.USD","BK4099","LU1989772840.SGD","MIAX","LU2265009873.SGD","LU2362541273.HKD","LU2491050071.SGD","BK4604","LU2506951958.HKD"],"gpt_icon":1},{"id":"2586210477","title":"Boston Scientific put volume heavy and directionally bearish","url":"https://stock-news.laohu8.com/highlight/detail?id=2586210477","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586210477?lang=en_us&edition=fundamental","pubTime":"2025-11-26 00:15","pubTimestamp":1764087316,"startTime":"0","endTime":"0","summary":"Bearish flow noted in Boston Scientific (BSX) with 1,475 puts trading, or 1.3x expected. Most active are Dec-25 96 puts and Dec-25 100 calls, with ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/boston-scientific-put-volume-heavy-and-directionally-bearish-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/boston-scientific-put-volume-heavy-and-directionally-bearish-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0267386448.USD","BSX","SGXZ57979304.SGD","LU2244417387.USD","LU1989772923.USD","LU2362541273.HKD","LU1057294990.SGD","LU2491050154.USD","IE00BJT1NW94.SGD","LU1989764748.USD","LU1791710400.SGD","LU2265009873.SGD","LU0528227936.USD","SG9999001176.USD","LU1061106388.HKD","LU2506951875.HKD","LU2087625088.SGD","LU0187121727.USD","LU0011850046.USD","LU2491049909.HKD","LU0345769631.USD","LU0251132253.USD","LU1720051108.HKD","IE00B4R5TH58.HKD","LU0048584097.USD","LU0238689110.USD","LU0114720955.EUR","LU1548497426.USD","SG9999001176.SGD","BK4504","LU1366192091.USD","SG9999013999.USD","LU2506951958.HKD","LU2491050071.SGD","LU1791710582.SGD","LU2357305700.SGD","LU1989771016.USD","IE00BJJMRZ35.SGD","LU1291159041.SGD","LU1983299246.USD","LU0122379950.USD","IE0002141913.USD","LU1989764664.SGD","LU2506952097.USD","LU2506952170.USD","LU1989772840.SGD","LU0225283273.USD","LU0823417653.USD","LU2362541513.USD","BK4585"],"gpt_icon":0},{"id":"2586183184","title":"Boston Scientific Corp. Stock Rises Monday, Still Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2586183184","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586183184?lang=en_us&edition=fundamental","pubTime":"2025-11-25 05:36","pubTimestamp":1764020160,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Boston Scientific Corp.  rose 1.20% to $98.04 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 1.55% to 6,705.12 and the Dow Jones Industrial Average  rising 0.44% to 46,448.27.This was the stock's second consecutive day of gains.Boston Scientific Corp. closed 10.47% below its 52-week high of $109.50, which the company achieved on September 9th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Abbott Laboratories  fell 0.72% to $127.19, Medtronic PLC  rose 1.98% to $103.20, and Stryker Corp.  rose 0.53% to $370.22.Trading volume  eclipsed its 50-day average volume of 10.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled November 24, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX"],"gpt_icon":0},{"id":"2585121151","title":"Boston Scientific Price Target Maintained With a $132.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2585121151","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585121151?lang=en_us&edition=fundamental","pubTime":"2025-11-21 19:09","pubTimestamp":1763723340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BSX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 21, 2025 06:09 ET (11:09 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX"],"gpt_icon":0},{"id":"2584197981","title":"Boston Scientific Approves 2026 Bonus Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2584197981","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584197981?lang=en_us&edition=fundamental","pubTime":"2025-11-20 05:56","pubTimestamp":1763589372,"startTime":"0","endTime":"0","summary":"Boston Scientific ( ($BSX) ) has provided an update. On November 18, 2025, Boston Scientific‘s Board of Directors approved the 2026 Annual Bonus Pl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/boston-scientific-approves-2026-bonus-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/boston-scientific-approves-2026-bonus-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1061106388.HKD","IE00B4R5TH58.HKD","LU0077335932.USD","LU1153585028.USD","LU1291159041.SGD","LU1791710400.SGD","IE00B2B36J28.USD","LU1366192091.USD","LU1989771016.USD","LU1804176565.USD","LU0823416689.USD","LU2324357040.USD","LU0432979614.USD","LU2242649171.HKD","LU0882574055.USD","BK4585","LU1718418525.SGD","BK4588","LU1983299246.USD","LU2491050154.USD","IE00BFTCPJ56.SGD","LU0011850046.USD","BSX","LU0950375773.USD","LU1791710582.SGD","LU0823417653.USD","IE0002141913.USD","LU0267386448.USD","IE00BJJMRZ35.SGD","LU1023059063.AUD","SGXZ57979304.SGD","LU0353189680.USD","LU1720051017.SGD","LU2362540622.SGD","BK4082","SG9999001176.SGD","LU0251132253.USD","LU2265009873.SGD","LU0345769128.USD","LU2491050071.SGD","LU0225283273.USD","BK4581","LU0122379950.USD","LU0823417737.USD","SG9999013999.USD","LU0048584097.USD","LU0353189763.USD","IE0009355771.USD","LU2112291526.USD","LU0266013472.USD"],"gpt_icon":0},{"id":"2584197660","title":"Boston Scientific Corp. Stock Outperforms Competitors Despite Losses On The Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2584197660","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584197660?lang=en_us&edition=fundamental","pubTime":"2025-11-20 05:36","pubTimestamp":1763588160,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Boston Scientific Corp.  slid 2.23% to $97.01 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.38% to 6,642.16 and the Dow Jones Industrial Average  rising 0.10% to 46,138.77.This was the stock's fourth consecutive day of losses.Boston Scientific Corp. closed 11.41% below its 52-week high of $109.50, which the company reached on September 9th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Abbott Laboratories  fell 2.96% to $126.15, Medtronic PLC  fell 0.46% to $100.34, and Stryker Corp.  rose 1.31% to $364.23.Trading volume  eclipsed its 50-day average volume of 9.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled November 19, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX"],"gpt_icon":0},{"id":"2584997578","title":"Boston Scientific Approves 2026 Executive Bonus and Performance Share Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2584997578","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584997578?lang=en_us&edition=fundamental","pubTime":"2025-11-20 05:21","pubTimestamp":1763587313,"startTime":"0","endTime":"0","summary":"Boston Scientific Corporation has approved its 2026 Annual Bonus Plan, which will provide eligible employees, including named executive officers, with annual cash incentives based on performance metrics for the year beginning January 1, 2026. The bonus pool is determined by multiplying total target bonuses by a distribution percentage, which the Compensation Committee will set between 0% and 150% based on the company's global sales, adjusted earnings per share, operating income as a percent of sales, and corporate sustainability goals. Additionally, the company has adopted two new performance share programs for 2026: one based on relative total shareholder return compared to the S&P 500 Healthcare Index over three years, and another focused on organic net sales growth. These programs are similar to those implemented in the previous year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDL9bS3WW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0077335932.USD","LU0345769128.USD","LU0122379950.USD","BSX","LU1989772923.USD","LU2244417387.USD","LU0048584097.USD","LU0353189680.USD","LU1291159041.SGD","LU1989771016.USD","BK4588","LU0267386448.USD","LU2265009873.SGD","LU2362540622.SGD","LU0432979614.USD","LU1153585028.USD","LU0353189763.USD","LU0187121727.USD","LU0345769631.USD","LU0266013472.USD","LU0950375773.USD","LU0882574055.USD","LU2506951875.HKD","BK4581","LU1720051017.SGD","IE00B4R5TH58.HKD","SGXZ57979304.SGD","LU1804176565.USD","IE0009355771.USD","LU1989772840.SGD","LU2506951958.HKD","LU2324357040.USD","LU2242649171.HKD","BK4504","BK4082","LU1983299246.USD","LU0823417737.USD","LU2506952097.USD","IE00BFTCPJ56.SGD","LU0225283273.USD","LU1023059063.AUD","LU2112291526.USD","LU2362541273.HKD","SG9999001176.SGD","SG9999013999.USD","LU0251132253.USD","LU1718418525.SGD","LU0823416689.USD","IE00B2B36J28.USD","BK4585"],"gpt_icon":0},{"id":"2584940345","title":"Analysts Are Bullish on These Healthcare Stocks: Fennec Pharmaceuticals (FENC), Boston Scientific (BSX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584940345","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584940345?lang=en_us&edition=fundamental","pubTime":"2025-11-19 22:40","pubTimestamp":1763563230,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Fennec Pharmaceuticals (FENC – Research Report) and ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-fennec-pharmaceuticals-fenc-boston-scientific-bsx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-fennec-pharmaceuticals-fenc-boston-scientific-bsx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BLSH","LU1983299246.USD","HCSG","LU0345769631.USD","LU2087625088.SGD","LU1720051017.SGD","LU0823416689.USD","LU0266013472.USD","LABU","LU0238689110.USD","LU2491049909.HKD","LU2491050154.USD","LU2506952097.USD","LU0882574055.USD","LU1057294990.SGD","BK4112","LU0011850046.USD","LU2491050071.SGD","XLV","LU1791710400.SGD","BK4504","BK4588","LU0187121727.USD","LU1291159041.SGD","LU2112291526.USD","LU0077335932.USD","LU1366192091.USD","LU2362540622.SGD","SG9999001176.USD","SGXZ57979304.SGD","FENC","IE00BJT1NW94.SGD","LU2506951875.HKD","LU0353189763.USD","LU0528227936.USD","LU2265009873.SGD","IE00BFTCPJ56.SGD","BSX","LU0823417737.USD","XBI","LU1989764748.USD","LU2324357040.USD","LU0432979614.USD","LU1153585028.USD","IE00B2B36J28.USD","LU2357305700.SGD","LU1548497426.USD","LU0128526141.USD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2584393125","title":"Medtronic beats second-quarter estimates on strength in heart devices segment","url":"https://stock-news.laohu8.com/highlight/detail?id=2584393125","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584393125?lang=en_us&edition=fundamental","pubTime":"2025-11-18 19:45","pubTimestamp":1763466300,"startTime":"0","endTime":"0","summary":"Medtronic beats second-quarter estimates on strength in heart devices segment Nov 18 (Reuters) - Medical device maker Medtronic MDT.N topped Wall Street estimates for second-quarter profit and revenue","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nL4N3WU0NU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX","LU2089284900.SGD","LU2506951875.HKD","LU0114720955.EUR","LU1983299246.USD","LU0158827781.USD","LU2271345857.HKD","MDT","LU0077335932.USD","LU2087625088.SGD","IE00BQXX3F31.USD","LU0225283273.USD","IE00BFXG0V08.USD","LU2506952170.USD","BK4533","LU2362541513.USD","LU1153585028.USD","LU2362540622.SGD","LU2023251221.USD","LU2244417387.USD","EW","LU2242649171.HKD","IE00BFTCPJ56.SGD","LU0251132253.USD","LU0950375773.USD","LU2089984988.USD","LU0345769128.USD","LU1244550577.SGD","LU2265009873.SGD","SG9999013999.USD","IE000M9KFDE8.USD","LU0266013472.USD","LU2362541273.HKD","LU0072461881.USD","LU0314106906.USD","LU0265550359.USD","LU0238689110.USD","LU1989764748.USD","BK4567","LU1116320737.USD","IE00BN0W2T93.GBP","LU1291159041.SGD","LU0496365809.HKD","LU0823417653.USD","IE00BJT1NW94.SGD","SG9999001176.SGD","BK4566","LU2089283258.USD","IE00BFXG1179.USD","IE00BQXX3D17.EUR"],"gpt_icon":0},{"id":"2584933835","title":"Acotec Scientific Wins PRC Approval for Coronary Over-the-Wire Balloon Catheter","url":"https://stock-news.laohu8.com/highlight/detail?id=2584933835","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584933835?lang=en_us&edition=fundamental","pubTime":"2025-11-18 17:55","pubTimestamp":1763459746,"startTime":"0","endTime":"0","summary":"Acotec Scientific Holdings Limited has announced that it has received registration approval from the PRC National Medical Products Administration for its Coronary Over-the-Wire Balloon Dilatation Catheter, Jingyi. The device is indicated for dilating coronary artery or coronary artery bypass vessel stenosis to improve myocardial perfusion, with certain configurations also approved for post-stent dilation. The company highlighted that Jingyi features a semi-compliant balloon and an optimized delivery system designed for improved crossability and pushability, making it suitable for complex lesions. Acotec plans to commence marketing activities for the product in the Chinese market at an appropriate time. The company cautioned that successful commercialization is not guaranteed. No other organizations were mentioned as recipients of this regulatory approval.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL4kXK6G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06669","IE00B4R5TH58.HKD","LU1983299246.USD","LU0114720955.EUR","LU2244417387.USD","LU0823417737.USD","LU0267386448.USD","LU1548497426.USD","LU2362540622.SGD","SG9999001176.SGD","LU2242649171.HKD","LU1718418525.SGD","LU2506952170.USD","LU1366192091.USD","BSX","LU0823417653.USD","LU1153585028.USD","LU2362541513.USD","LU1791710582.SGD","LU2357305700.SGD","IE0009355771.USD","LU1061106388.HKD","BK1587","BK1574","LU0882574055.USD","BK4082","LU2362541273.HKD","IE0002141913.USD","BK4585","LU2506951958.HKD","LU0353189680.USD","LU0225283273.USD","LU0345769631.USD","LU2491049909.HKD","LU0122379950.USD","BK4504","LU0528227936.USD","LU1804176565.USD","LU1989771016.USD","BK1100","LU2491050154.USD","LU0048584097.USD","LU0266013472.USD","SG9999001176.USD","LU1720051108.HKD","LU2506952097.USD","LU0251132253.USD","LU2491050071.SGD","LU1720051017.SGD","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2583868470","title":"Boston Scientific Corp. Stock Underperforms Friday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2583868470","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583868470?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:35","pubTimestamp":1763156100,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Boston Scientific Corp.  shed 2.18% to $102.69 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.05% to 6,734.11 and Dow Jones Industrial Average  falling 0.65% to 47,147.48.The stock's fall snapped an eight-day winning streak.Boston Scientific Corp. closed 6.22% below its 52-week high of $109.50, which the company reached on September 9th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Abbott Laboratories  rose 1.03% to $130.59, Medtronic PLC  fell 0.28% to $95.87, and Stryker Corp.  fell 3.00% to $362.22.Data source: Dow Jones Market Data, FactSet. Data compiled November 14, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX"],"gpt_icon":0},{"id":"2583518907","title":"A stock market that could only go up now seems to need direction","url":"https://stock-news.laohu8.com/highlight/detail?id=2583518907","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583518907?lang=en_us&edition=fundamental","pubTime":"2025-11-14 01:54","pubTimestamp":1763056440,"startTime":"0","endTime":"0","summary":"The U.S. government shutdown has ended and the S&P 500 SPX has been pushing against resistance at 6,900 . The first support is at 6,630, and below that is strong support at 6,500 to 6,550.The S&P 500's decline last week closed two recent gaps on the SPX chart. Earlier this week, SPX gapped higher on the end-of-the-shutdown rally. That gap is circled on the SPX chart below.Implied volatility - the VIX complex of indicators - has remained bullish, but just barely. VIX VIX spiked toward 23 at the worst of the selling on Nov. 7 but fell back sharply by that day's end. Because VIX never closed above its 200-day moving average for two consecutive days, the VIX-related buy signals that we had in place remained intact.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2322448957.HKD","LU2322448791.USD","IE00B4R5TH58.HKD","LU2506951875.HKD","SSO","LU2506951958.HKD","LU0731783394.SGD","LU1291159041.SGD","CME","OEX","LU0267386448.USD","VXX","BSX","MESmain","LU0158827948.USD","UPRO","BK4566","VXMmain","IE00B3CCJ633.GBP","ESmain","LU0772969993.USD","OEF","SG9999014906.USD","LU1983299246.USD","VIXmain","BK4581","UVXY","SH","LU0353189763.USD","BK4550","SG9999014880.SGD","LU0238689110.USD","LU1992135399.USD","SPY","TSEM","IE0034235188.USD","SVXY","TVIX","SPXU","BK4223","LU0912757837.SGD","LU1989764748.USD","BXP","IE00BJJMRZ35.SGD","SDS","IVV","APH","VIXY","LU1116320901.HKD"],"gpt_icon":0},{"id":"2582463345","title":"RISE is pleased to announce the acquisition of BSX Labs. 1.5% of the total supply of RISE tokens will be allocated to the circulating BSX tokens.","url":"https://stock-news.laohu8.com/highlight/detail?id=2582463345","media":"Blockbeats","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582463345?lang=en_us&edition=fundamental","pubTime":"2025-11-12 12:31","pubTimestamp":1762921860,"startTime":"0","endTime":"0","summary":"BlockBeats News, November 12, Ethereum Layer 2 network RISE announced the acquisition of the team behind the Base network Perpetual DEX platform BSX, BSX Labs.BSX Labs will assist RISE in developing an EVM-compatible, composable order book infrastructure to bridge the gap with traditional financial markets.BSX token holders will be eligible to receive an airdrop of RISE's upcoming native token, with 1.5% of the total RISE token supply being allocated to the currently circulating BSX token. The BSX DEX will officially close on November 11, 2025, at 15:00 .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"theblockbeats_live","url":"https://www.theblockbeats.info//en/flash/320105","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/320105","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["LU1023059063.AUD","BK4585","LU2362541273.HKD","LU1061106388.HKD","IE00BJT1NW94.SGD","LU1989771016.USD","LU2265009873.SGD","LU2491049909.HKD","SG9999013999.USD","LU2491050154.USD","LU0950375773.USD","LU2324357040.USD","BK4504","LU0238689110.USD","LU0077335932.USD","SGXZ57979304.SGD","LU2362540622.SGD","LU1291159041.SGD","ETH.USD.HKCC","LU1548497426.USD","LU2362541513.USD","LU0011850046.USD","LU1791710400.SGD","LU2506951958.HKD","LU2506952170.USD","BSX","IE00BFTCPJ56.SGD","LU0048584097.USD","LU0266013472.USD","LU1718418525.SGD","LU1720051108.HKD","LU2087625088.SGD","LU0225283273.USD","LU1720051017.SGD","LU2506952097.USD","LU0882574055.USD","LU1366192091.USD","LU2506951875.HKD","IE00B2B36J28.USD","ETH.USD.CC","IE00BJJMRZ35.SGD","LU2491050071.SGD","IE0009355771.USD","LU0823416689.USD","RISE","LU1153585028.USD","LU0187121727.USD","LU1989764748.USD","LU0823417653.USD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.bostonscientific.com","stockEarnings":[{"period":"1week","weight":-0.0507},{"period":"1month","weight":-0.1109},{"period":"3month","weight":-0.0986},{"period":"6month","weight":-0.0718},{"period":"1year","weight":0.0239},{"period":"ytd","weight":0.0365}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.0541},{"month":2,"riseRate":0.545455,"avgChangeRate":0.003989},{"month":3,"riseRate":0.575758,"avgChangeRate":0.02551},{"month":4,"riseRate":0.666667,"avgChangeRate":0.018678},{"month":5,"riseRate":0.606061,"avgChangeRate":0.020467},{"month":6,"riseRate":0.5,"avgChangeRate":0.004921},{"month":7,"riseRate":0.617647,"avgChangeRate":0.019016},{"month":8,"riseRate":0.441176,"avgChangeRate":0.003398},{"month":9,"riseRate":0.382353,"avgChangeRate":-0.02534},{"month":10,"riseRate":0.470588,"avgChangeRate":0.00099},{"month":11,"riseRate":0.470588,"avgChangeRate":-0.01032},{"month":12,"riseRate":0.764706,"avgChangeRate":0.035395}],"exchange":"NYSE","name":"Boston Scientific","nameEN":"Boston Scientific"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Boston Scientific(BSX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Boston Scientific(BSX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Boston Scientific,BSX,Boston Scientific股票,Boston Scientific股票老虎,Boston Scientific股票老虎国际,Boston Scientific行情,Boston Scientific股票行情,Boston Scientific股价,Boston Scientific股市,Boston Scientific股票价格,Boston Scientific股票交易,Boston Scientific股票购买,Boston Scientific股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Boston Scientific(BSX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Boston Scientific(BSX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction